A recent chemical spill of 4-Methylcyclohexanemethanol (4-MCHM) in West Virginia left 300,000 people without water. Officials claimed that this compound is not lethally toxic, but potentially harmful if swallowed or inhaled, and can cause eye and skin irritation. Sittig's Handbook of Toxic and Hazardous Chemical Carcinogens reports high exposures from skin contact or inhalation may cause damage to the heart, liver, kidneys, and lungs, and may result in death. However, no quantitative data seem to exist and no references can be found on neurotoxicity. We have investigated the neurotoxicity of 4-MCHM using mammalian nerve cell networks grown on microelectrode arrays. Network spontaneous activity from multiple units (range 48 – 120 per network) were used as the primary readout. Individual units were followed based on spike waveforms digitized at 40 kHz (Plexon MNAP system). Dose response curves show the effective inhibitory concentration at 50 percent decrease (EC50) to average 27.4 microM SD±6.17. However, in the presence of 40 microM bicuculline, a competitive GABAA antagonist, the EC50 shifts to 70.63uM SD ±4.3; implying that early, low concentration exposures to 4-MCHM involve GABA activation. Initial activity loss occurs without active unit loss (defined as 10 or more template threshold crossing per min), indicating functional interference with spike production. Full recovery has not been seen at concentrations above 130 microM, unless the culture was given bicuculline. Direct exposure to 400uM results in immediate, irreversible loss of spike production, followed by necrosis of glia and neurons.

Hydrocarbon solvents are widely used in the production of paints, adhesives, dyes, polymers, plastics, textiles, printing inks, agricultural products and pharmaceuticals. While the neuropathic potential of aliphatic solvents was shown in the 1970s, little is known about the neuropathic potential of aromatic solvents. The present study examines such solvents, 1,2-diethylbenzene (DEB) and its metabolite 1,2-diacetylbenzene (DAB), to determine (a) the neuropathological evidence for peripheral neuropathy in rodents treated with 1,2-DAB, (b) the neurochemical basis for the neurotoxic properties of this compound, and (c) the structural requirements for nerve fiber damage. The properties of 1,2-DAB and 2,5- hexanedione (HD) are also compared. A key finding of this thesis is that 1,2-DAB induces a 2,5-HD-like pattern of nerve damage of motor and sensory axons with focal swellings containing neurofilaments. Whereas nerve damage begins distally in 2,5-HD intoxication, with 1,2-DAB treatment axonal swellings begin intraspinally and in the proximal ventral roots of motor nerve fibers. A second key finding is the reactivity of 1,2-DAB with amino acids, notably lysine, a property that is shared with 2,5-HD. 1,2-DAB and 2,5-HD react with amino acids and proteins to form blue and yellow chromophores, respectively. Relative to 2,5-HD, 1,2-DAB is three orders of magnitude more reactive in forming high-molecular-weight species. 1,2-DAB treatment of spinal cord slices in vitro and intact sciatic nerve in vivo showed that neurofilament proteins react more readily than beta-tubulin. The heavy and medium subunits of neurofilament protein were more reactive than the light subunit. The reactivity of these four axonal proteins was in proportion to their lysine content. These data are consistent with selective accumulation of neurofilaments in giant axonal swellings. In summary, these studies have shown a relationship between the chromogenic and neuropathic properties of two gamma-diketones, one aliphatic (2,5-HD) the other aromatic (1,2-DAB). These studies are relevant to occupational and public health for at least two reasons. First, urinary chromogens generated by neuropathic aliphatic and aromatic hydrocarbons could serve as biological markers of exposure to solvents with neuropathic potential, and second, other chromogenic solvents (such as tetralin) should be considered for neuropathic potential. / Graduation date: 2002